RxDoctor Payments Data

John Griswold, MD

Surgical Critical Care · Lubbock, TXNPI 1720062789

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $14,464 of the $21,057 with a category attached, or 68.7%. Medline Industries LP accounts for 85.4% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $14,892 and has fallen 98.8% since, to $175 in 2025.

$21,057in general payments, 2019–2025

Across 83 payments — averaging $253.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medline Industries LP$18K
  • Avita Medical Americas, LLC$1K
  • Vericel Corporation$654
  • Smith+Nephew$214
  • Integra Lifesciences Corporation$163
  • Derma Sciences, Inc.$157
  • plus $763 from 17 others
$14,635in research payments, 2019–2025

Across 1 payment — averaging $14,635 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vericel Corporation$15K

What the payments were for

  • Consulting fees$1,4057%
  • Speaking & faculty fees$14,46469%
  • Travel & lodging$2,30111%
  • Food & beverage$2,82413%
  • Education$630%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,057 in reported general payments places this provider in the 85th percentile of 104 surgical critical care providers in Texas.

See all surgical critical care providers in Texas

Medicare billing

Part B allowed, 2024
$14,731
Medicare patients
21
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical critical care in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →